BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$1.37B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$757M |
| 4 |
NXP Semiconductors
NXPI
|
+$755M |
| 5 |
Altria Group
MO
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$2.22B |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$1.02B |
| 3 |
CSC
Computer Sciences
CSC
|
+$901M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$876M |
| 5 |
VAL
Valspar
VAL
|
+$746M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.96% |
| 2 | Technology | 14.01% |
| 3 | Healthcare | 13.65% |
| 4 | Industrials | 10.15% |
| 5 | Consumer Discretionary | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
3976
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $364K | ﹤0.01% |
115,065
-15,388
| -12% | -$48.6K |
|
|
ARIS
3977
DELISTED
ARI Network Services, Inc.
ARIS
| $362K | ﹤0.01% |
51,400
+39,820
| +344% | +$222K |
|
|
SBB
3978
DELISTED
SUSSEX BANCORP
SBB
| $360K | ﹤0.01% |
14,807
+13,375
| +934% | +$325K |
|
|
CDTX
3979
DELISTED
Cidara Therapeutics
CDTX
| $356K | ﹤0.01% |
2,377
-26,620
| -92% | -$3.68M |
|
3980
LifeVantage
LFVN
$79.9M
| $356K | ﹤0.01% |
82,017
-559,733
| -87% | -$2.47M |
|
|
SYNC
3981
DELISTED
Synacor, Inc.
SYNC
| $356K | ﹤0.01% |
97,606
+15,986
| +20% | +$56.8K |
|
3982
ClearSign Technologies
CLIR
$26.5M
| $355K | ﹤0.01% |
9,340
-13
| -0.1% | -$477 |
|
|
WBB
3983
DELISTED
Westbury Bancorp, Inc.
WBB
| $354K | ﹤0.01% |
16,973
-935
| -5% | -$19.1K |
|
3984
Plus Therapeutics
PSTV
$26.6M
| $353K | ﹤0.01% |
2
| – | – |
|
3985
Criteo S.A. Ordinary Shares
CRTO
$1.08B
| $351K | ﹤0.01% |
7,142
| – | – |
|
3986
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
| $350K | ﹤0.01% |
6,998
+682
| +11% | +$33.7K |
|
|
WSCI
3987
DELISTED
WSI Industries Inc
WSCI
| $349K | ﹤0.01% |
107,389
-4,205
| -4% | -$13.3K |
|
3988
United-Guardian
UG
$33.1M
| $336K | ﹤0.01% |
21,730
-640
| -3% | -$9.51K |
|
|
BCLI
3989
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $335K | ﹤0.01% |
5,384
+246
| +5% | +$15.2K |
|
3990
Achieve Life Sciences
ACHV
$654M
| $334K | ﹤0.01% |
422
-13
| -3% | -$10.5K |
|
|
BIOA
3991
DELISTED
BioAmber Inc.
BIOA
| $334K | ﹤0.01% |
130,043
-13,611
| -9% | -$31.3K |
|
|
KDMN
3992
DELISTED
Kadmon Holdings, Inc.
KDMN
| $332K | ﹤0.01% |
85,330
-190,077
| -69% | -$538K |
|
3993
Data I/O
DAIO
$29.8M
| $331K | ﹤0.01% |
41,683
+27,180
| +187% | +$181K |
|
3994
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
| $330K | ﹤0.01% |
2,979
+808
| +37% | +$89.5K |
|
|
VIRX
3995
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $328K | ﹤0.01% |
3,471
+1,113
| +47% | +$128K |
|
|
MNTX
3996
DELISTED
Manitex International, Inc.
MNTX
| $327K | ﹤0.01% |
46,792
+811
| +2% | +$5.67K |
|
3997
ICL Group
ICL
$6.57B
| $326K | ﹤0.01% |
68,850
+14,420
| +26% | +$62.1K |
|
|
STLY
3998
DELISTED
Stanley Furniture Co Inc
STLY
| $325K | ﹤0.01% |
284,881
-34,172
| -11% | -$36.3K |
|
3999
ING
ING
$101B
| $324K | ﹤0.01% |
18,630
+1,745
| +10% | +$28.7K |
|
|
VXRT
4000
DELISTED
Vaxart
VXRT
| $324K | ﹤0.01% |
43,994
-9,686
| -18% | -$57.9K |
|
Similar funds
BlackRock's Q2 2017 Portfolio in Review
As of Q2 2017, BlackRock held 5,247 positions worth $1.89T, up 3.5% from $1.82T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlackRock's Q2 2017 filing shows 178 new, 2,463 increased, 1,954 reduced and 183 closed positions. Its largest new stake was DXC Technology: 20,612,848 shares worth $1.37B. The largest sale was Yahoo Inc, an estimated $2.22B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- BlackRock's largest Q2 2017 buy was DXC Technology: 20,612,848 shares worth $1.37B.
- BlackRock added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $1.09B increase.
- BlackRock's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $685M.
- BlackRock fully exited Yahoo Inc in Q2 2017, selling an estimated $2.22B.
- BlackRock's ten largest holdings make up 13% of its $1.89T portfolio in Q2 2017.
- BlackRock opened 178 new positions and closed 183 in Q2 2017.
- BlackRock's portfolio value rose 3.5% quarter-over-quarter to $1.89T.
Based on BlackRock's 13F filing for Q2 2017, filed 10 Aug 2017.